The authors of Yet another paper described the administration of HBOT as adjuvant therapy for acute macular neuroretinopathy in systemic lupus erythematosus in conjunction with immunosuppression in two patients [eleven]. OPDIVO® (nivolumab) is actually a prescription medicine applied to treat